{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T15:55:08Z","timestamp":1718553308125},"reference-count":50,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology in Vitro"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.tiv.2013.04.014","type":"journal-article","created":{"date-parts":[[2013,5,13]],"date-time":"2013-05-13T16:02:06Z","timestamp":1368460926000},"page":"1753-1761","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Human T47D-ER\u03b2 breast cancer cells with tetracycline-dependent ER\u03b2 expression reflect ER\u03b1\/ER\u03b2 ratios in rat and human breast tissue"],"prefix":"10.1016","volume":"27","author":[{"given":"N.M.","family":"Evers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.M.C.","family":"van de Klundert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.M.","family":"van Aesch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.K.","family":"de Roos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Romano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.H.J.","family":"de Haan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.J.","family":"Murk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.G.H.","family":"Ederveen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.M.C.M.","family":"Rietjens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.P.","family":"Groten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tiv.2013.04.014_b0005","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1158\/1078-0432.CCR-07-0320","article-title":"The effect of repeated administration of cyclophosphamide on cytochrome P450 2B in rats","volume":"13","author":"Afsharian","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tiv.2013.04.014_b0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1001\/jama.1923.02650100027012","article-title":"An ovarian hormone; a preliminary report on its localization, extraction, partial purification, and action in test animals","volume":"81","author":"Allen","year":"1923","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.tiv.2013.04.014_b0255","article-title":"Opposing roles of ERalpha and ERbeta in the genesis and progression of adenocarcinoma in the rat ventral prostate","author":"Attia","year":"2011","journal-title":"Prostate"},{"key":"10.1016\/j.tiv.2013.04.014_b0020","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/j.fertnstert.2007.09.019","article-title":"Estrogen receptor alpha and beta in uterine fibroids: a basis for altered estrogen responsiveness","volume":"90","author":"Bakas","year":"2008","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.tiv.2013.04.014_b0025","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1677\/erc.1.00800","article-title":"Loss of ERbeta expression as a common step in estrogen-dependent tumor progression","volume":"11","author":"Bardin","year":"2004","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.tiv.2013.04.014_b0030","doi-asserted-by":"crossref","first-page":"5861","DOI":"10.1158\/0008-5472.CAN-04-0552","article-title":"Involvement of estrogen receptor beta in ovarian carcinogenesis","volume":"64","author":"Bardin","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.tiv.2013.04.014_b0035","first-page":"4258","article-title":"Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern","volume":"82","author":"Enmark","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tiv.2013.04.014_b0040","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/pros.10171","article-title":"Differential expression of the estrogen receptor beta (ERbeta) in human prostate tissue, premalignant changes, and in primary, metastatic, and recurrent prostatic adenocarcinoma","volume":"54","author":"Fixemer","year":"2003","journal-title":"Prostate"},{"key":"10.1016\/j.tiv.2013.04.014_b0045","doi-asserted-by":"crossref","first-page":"e1000108","DOI":"10.1371\/journal.pgen.1000108","article-title":"Metabolic actions of estrogen receptor beta (ERbeta) are mediated by a negative cross-talk with PPARgamma","volume":"4","author":"Foryst-Ludwig","year":"2008","journal-title":"PLoS Genet."},{"key":"10.1016\/j.tiv.2013.04.014_b0050","first-page":"3693","article-title":"Interaction of phenol red with estrogenic and antiestrogenic action on growth of human breast cancer cells ZR-75-1 and T-47-D","volume":"48","author":"Glover","year":"1988","journal-title":"Cancer Res"},{"key":"10.1016\/j.tiv.2013.04.014_b0055","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1210\/mend.11.11.0006","article-title":"Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27 (Kip1)","volume":"11","author":"Groshong","year":"1997","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.tiv.2013.04.014_b0060","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00280-008-0842-3","article-title":"Nuclear receptor mediated induction of cytochrome P450 3A4 by anticancer drugs: a key role for the pregnane X receptor","volume":"64","author":"Harmsen","year":"2009","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.tiv.2013.04.014_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/me.2005-0459","article-title":"Estrogen receptor-beta: recent lessons from in vivo studies","volume":"21","author":"Harris","year":"2007","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.tiv.2013.04.014_b0070","doi-asserted-by":"crossref","first-page":"11207","DOI":"10.1158\/0008-5472.CAN-06-0017","article-title":"Estrogen receptor beta inhibits angiogenesis and growth of T47D breast cancer xenografts","volume":"66","author":"Hartman","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.tiv.2013.04.014_b0075","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1677\/erc.0.0100193","article-title":"The expression and function of estrogen receptor alpha and beta in human breast cancer and its clinical application","volume":"10","author":"Hayashi","year":"2003","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.tiv.2013.04.014_b0080","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/sj.gene.6364190","article-title":"Real-time RT-PCR normalisation; strategies and considerations","volume":"6","author":"Huggett","year":"2005","journal-title":"Genes Immun."},{"key":"10.1016\/j.tiv.2013.04.014_b0085","doi-asserted-by":"crossref","first-page":"9375","DOI":"10.1073\/pnas.0403041101","article-title":"Estrogen receptor beta regulates epithelial cellular differentiation in the mouse ventral prostate","volume":"101","author":"Imamov","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.tiv.2013.04.014_b0090","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1210\/endo.138.3.4979","article-title":"Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta","volume":"138","author":"Kuiper","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.tiv.2013.04.014_b0095","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.canlet.2005.01.021","article-title":"Estrogen receptor beta, a possible tumor suppressor involved in ovarian carcinogenesis","volume":"231","author":"Lazennec","year":"2006","journal-title":"Cancer Lett."},{"key":"10.1016\/j.tiv.2013.04.014_b0100","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1210\/endo.142.9.8395","article-title":"ER beta inhibits proliferation and invasion of breast cancer cells","volume":"142","author":"Lazennec","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.tiv.2013.04.014_b0105","first-page":"3197","article-title":"Altered estrogen receptor alpha and beta messenger RNA expression during human breast tumorigenesis","volume":"58","author":"Leygue","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.tiv.2013.04.014_b0260","article-title":"Heterochromatin, from Chromosome to Protein","author":"Mattei","year":"2003","journal-title":"Atlas Genet. Cytogen. Oncol. Haematol."},{"key":"10.1016\/j.tiv.2013.04.014_b0115","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1210\/me.2005-0140","article-title":"Estrogen receptor (ER) beta modulates ERalpha-mediated transcriptional activation by altering the recruitment of c-Fos and c-Jun to estrogen-responsive promoters","volume":"20","author":"Matthews","year":"2006","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.tiv.2013.04.014_b0120","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1210\/me.2004-0381","article-title":"Estrogen receptor alpha and beta heterodimers exert unique effects on estrogen- and tamoxifen-dependent gene expression in human U2OS osteosarcoma cells","volume":"19","author":"Monroe","year":"2005","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.tiv.2013.04.014_b0125","doi-asserted-by":"crossref","first-page":"5032","DOI":"10.1128\/MCB.11.10.5032","article-title":"Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor alpha, epidermal growth factor receptor, c-fos, and c-myc genes","volume":"11","author":"Musgrove","year":"1991","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.tiv.2013.04.014_b0130","first-page":"6056","article-title":"The selective estrogen receptor modulator trioxifene (LY133314) inhibits metastasis and extends survival in the PAIII rat prostatic carcinoma model","volume":"63","author":"Neubauer","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.tiv.2013.04.014_b0135","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1152\/physrev.2001.81.4.1535","article-title":"Mechanisms of estrogen action","volume":"81","author":"Nilsson","year":"2001","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.tiv.2013.04.014_b0140","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1158\/0008-5472.CAN-03-2446","article-title":"Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest","volume":"64","author":"Paruthiyil","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.tiv.2013.04.014_b0145","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.critrevonc.2003.09.003","article-title":"The biological role of estrogen receptors alpha and beta in cancer","volume":"50","author":"Pearce","year":"2004","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.tiv.2013.04.014_b0150","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1677\/erc.1.01026","article-title":"The mechanisms and managements of hormone-therapy resistance in breast and prostate cancers","volume":"12","author":"Rau","year":"2005","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.tiv.2013.04.014_b0155","unstructured":"Roche, A.S., 2007. Cell Proliferation ELISA, BrdU (colorimetric) Instruction Manual."},{"key":"10.1016\/j.tiv.2013.04.014_b0160","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/PGP.0b013e31820918cb","article-title":"Comparative analysis of the ERalpha\/ERbeta ratio and neurotensin and its high-affinity receptor in myometrium, uterine leiomyoma, atypical leiomyoma, and leiomyosarcoma","volume":"30","author":"Rodriguez","year":"2011","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.tiv.2013.04.014_b0165","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S1385-299X(02)00219-2","article-title":"The measurement of adenosine and estrogen receptor expression in rat brains following ovariectomy using quantitative PCR analysis","volume":"11","author":"Rose\u2019Meyer","year":"2003","journal-title":"Brain Res. Brain Res. Protoc."},{"key":"10.1016\/j.tiv.2013.04.014_b0170","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1477-5956-8-61","article-title":"Clinical application for the preservation of phospho-proteins through in situ tissue stabilization","volume":"8","author":"Rountree","year":"2010","journal-title":"Proteome Sci."},{"key":"10.1016\/j.tiv.2013.04.014_b0175","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1677\/joe.0.1680447","article-title":"Estrogen receptors alpha and beta in the normal, hyperplastic and carcinomatous human prostate","volume":"168","author":"Royuela","year":"2001","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.tiv.2013.04.014_b0180","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0029-7844(00)00917-0","article-title":"Absence of estrogen receptor-beta expression in metastatic ovarian cancer","volume":"96","author":"Rutherford","year":"2000","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.tiv.2013.04.014_b0185","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0039-128X(98)00054-3","article-title":"Comparative distribution of estrogen receptor-alpha (ER-alpha) and beta (ER-beta) mRNA in the rat pituitary, gonad, and reproductive tract","volume":"63","author":"Shughrue","year":"1998","journal-title":"Steroids"},{"key":"10.1016\/j.tiv.2013.04.014_b0195","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jsbmb.2008.10.002","article-title":"Phytoestrogen-mediated inhibition of proliferation of the human T47D breast cancer cells depends on the ERalpha\/ERbeta ratio","volume":"112","author":"Sotoca","year":"2008","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.tiv.2013.04.014_b0200","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/toxsci\/kfn141","article-title":"Influence of cellular ERalpha\/ERbeta ratio on the ERalpha-agonist induced proliferation of human T47D breast cancer cells","volume":"105","author":"Sotoca","year":"2008","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tiv.2013.04.014_b0265","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M110.002170","article-title":"Quantitative proteomics and transcriptomics addressing the estrogen receptor subtype-mediated effects in T47D breast cancer cells exposed to the phytoestrogen genistein","volume":"10","author":"Sotoca","year":"2011","journal-title":"Mol. Cell Proteomics"},{"key":"10.1016\/j.tiv.2013.04.014_b0205","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1210\/en.2003-1682","article-title":"Transcriptional profiling of estrogen-regulated gene expression via estrogen receptor (ER) alpha or ERbeta in human osteosarcoma cells: distinct and common target genes for these receptors","volume":"145","author":"Stossi","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.tiv.2013.04.014_b0210","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1073\/pnas.0308319100","article-title":"Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D","volume":"101","author":"Str\u00f6m","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.tiv.2013.04.014_b0215","first-page":"3993","article-title":"Inhibition of endometrial carcinoma cell growth using antisense estrogen receptor oligodeoxyribonucleotides","volume":"22","author":"Taylor","year":"2002","journal-title":"Anticancer Res."},{"key":"10.1016\/j.tiv.2013.04.014_b0220","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrc3093","article-title":"The different roles of ER subtypes in cancer biology and therapy","volume":"11","author":"Thomas","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.tiv.2013.04.014_b0230","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1095\/biolreprod61.4.955","article-title":"A comparative study of estrogen receptors alpha and beta in the rat uterus","volume":"61","author":"Wang","year":"1999","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.tiv.2013.04.014_b0225","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1095\/biolreprod63.5.1331","article-title":"Estrogen receptors alpha and beta in the female reproductive tract of the rat during the estrous cycle","volume":"63","author":"Wang","year":"2000","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.tiv.2013.04.014_b0235","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0014-5793(03)00436-8","article-title":"Update on estrogen signaling","volume":"546","author":"Weihua","year":"2003","journal-title":"FEBS Lett."},{"key":"10.1016\/j.tiv.2013.04.014_b0240","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1172\/JCI28550","article-title":"Estrogen deficiency and bone loss: an inflammatory tale","volume":"116","author":"Weitzmann","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tiv.2013.04.014_b0245","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/sj.onc.1210712","article-title":"A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells","volume":"27","author":"Williams","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.tiv.2013.04.014_b0250","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1089\/rej.2009.1015","article-title":"Acetaminophen improves protein translational signaling in aged skeletal muscle","volume":"13","author":"Wu","year":"2010","journal-title":"Rejuvenation Res."}],"container-title":["Toxicology in Vitro"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233313001215?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233313001215?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,13]],"date-time":"2019-07-13T15:17:02Z","timestamp":1563031022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887233313001215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0887233313001215"],"URL":"https:\/\/doi.org\/10.1016\/j.tiv.2013.04.014","relation":{},"ISSN":["0887-2333"],"issn-type":[{"value":"0887-2333","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human T47D-ER\u03b2 breast cancer cells with tetracycline-dependent ER\u03b2 expression reflect ER\u03b1\/ER\u03b2 ratios in rat and human breast tissue","name":"articletitle","label":"Article Title"},{"value":"Toxicology in Vitro","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tiv.2013.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}